| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |